China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.400
-0.035 (-1.44%)
At close: Sep 18, 2026, 4:00 PM EDT
2.350
-0.050 (-2.08%)
After-hours: Sep 18, 2026, 7:47 PM EDT
China SXT Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
| 3 | 1 | 182 | 34 | 3 | 1 | 1 | 3 | 2 | - | - | |
Market Cap Growth (YoY) | -98.61% | -95.82% | 7122.44% | 4154.69% | 70.89% | -70.38% | -20.13% | - | - | - | - |
Enterprise Value | -24 | -19 | 165 | 26 | -6 | -8 | -7 | 1 | -2 | - | - |
Last Close Price | 2.40 | 134.40 | 18839.89 | 29938.63 | 70060.58 | 161279.48 | 295176.39 | 680585.55 | 1847852.17 | 13461538.46 | 49519230.77 |
Price Ratios
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | -0.23 | - | - | - | -0.26 | - | - | - | - | - |
PS Ratio | 2.79 | 1.26 | 118.44 | 19.71 | 1.39 | 0.42 | 0.87 | 1.38 | 0.66 | - | - |
PB Ratio | 0.11 | 0.05 | 9.00 | 2.22 | 0.17 | 0.06 | 0.29 | 0.19 | 0.12 | - | - |
P/TBV Ratio | 0.11 | 0.05 | 9.01 | 2.22 | 0.17 | 0.06 | 0.29 | 0.19 | 0.12 | - | - |
P/FCF Ratio | - | - | - | - | - | - | - | -17.98 | - | - | - |
P/OCF Ratio | - | - | - | - | - | - | - | -33.71 | - | - | - |
EV Ratios
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | - | - | 107.23 | 14.75 | - | - | - | 0.67 | - | - | - |
EV/FCF Ratio | - | - | - | - | - | - | - | -8.69 | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.06 | 0.06 | 0.66 | 0.27 | 0.70 | 0.61 | 0.11 | 0.65 | 0.19 |
Debt / FCF Ratio | - | - | - | - | - | - | - | -59.17 | - | 52.20 | - |
Net Debt / Equity Ratio | -0.92 | -0.92 | -0.99 | -1.12 | -0.57 | -0.60 | -1.55 | -0.57 | -0.09 | -0.29 | 0.19 |
Net Debt / EBITDA Ratio | 3.86 | 3.86 | 2.41 | 6.64 | -1.27 | 4.43 | 0.60 | 1.68 | 0.44 | 0.98 | -0.44 |
Net Debt / FCF Ratio | 6.77 | 6.77 | 7.33 | 7.35 | 3.19 | 4.33 | 48.79 | 55.52 | 46.93 | -23.24 | -2.01 |
Return on Capital Employed (ROCE) | -23.40% | -23.40% | -41.10% | -17.10% | 43.20% | -14.70% | -249.80% | -34.90% | -23.20% | -31.60% | -45.30% |
Yields
Fiscal Quarter | Current | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | -195.66% | -432.74% | -4.87% | -9.63% | 229.76% | -384.24% | -957.82% | -218.00% | -223.98% | - | - |
FCF Yield | -126.68% | -280.17% | -1.51% | -6.84% | -107.56% | -239.97% | -10.96% | -5.56% | -1.62% | - | - |
Buyback Yield / Dilution | - | - | - | - | - | - | - | - | - | 86.91% | 72.81% |